The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Quintiles Transnational Holdings Inc

NYSE: Q
Last

(U.S.) $58.81

Today's change+2.11 +3.71%
Updated February 10 2:57 PM EST. Delayed by at least 15 minutes.
 

Quintiles Transnational Holdings Inc

NYSE: Q
Last

(U.S.) $58.81

Today's change+2.11 +3.71%
Updated February 10 2:57 PM EST. Delayed by at least 15 minutes.

Quintiles Transnational Holdings Inc up sharply

Quintiles Transnational Holdings Inc is up sharply today, rallying (U.S.)$2.11 or 3.71% to (U.S.)$58.81. Over the last five days, shares have gained 0.44%, but are down 14.35% for the last year to date. Shares have outperformed the S&P 500 by 7.72% during the last year.

Key company metrics

  • Open(U.S.) $56.93
  • Previous close(U.S.) $56.70
  • High(U.S.) $60.36
  • Low(U.S.) $56.60
  • Bid / Ask(U.S.) $58.80 / (U.S.) $58.85
  • YTD % change-14.35%
  • Volume1,151,595
  • Average volume (10-day)1,227,742
  • Average volume (1-month)999,507
  • Average volume (3-month)921,521
  • 52-week range(U.S.) $55.01 to (U.S.) $80.45
  • Beta--
  • Trailing P/E20.11×
  • P/E 1 year forward17.17×
  • Forward PEG1.23×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.92
Updated February 10 2:57 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.51%

Based on its net profit margin of 6.51%, Quintiles Transnational Holdings Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.37%Sector:HealthcareIndustry:Biotechnology

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue1,4251,4441,3481,411
Total other revenue--------
Total revenue1,4251,4441,3481,411
Gross profit410391368389
Total cost of revenue1,0141,0539791,022
Total operating expense1,2581,2931,2041,252
Selling / general / administrative231226220225
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)121455
Other operating expenses, total--------
Operating income167151143159
Interest income (expense), net non-operating-25-25-25-26
Gain (loss) on sale of assets--------
Other--------
Income before tax144115122133
Income after tax103838694
Income tax, total40323639
Net income111858688
Total adjustments to net income--------
Net income before extra. items111858688
Minority interest2000
Equity in affiliates521-5
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items111858688
Inc. avail. to common incl. extra. items111858688
Diluted net income111858688
Dilution adjustment------0
Diluted weighted average shares125127127129
Diluted EPS excluding extraordinary itemsvalue per share0.890.670.680.69
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.960.750.710.72